Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: The meta-analysis may be influenced by 'geographical weighting'

G. Losurdo, G. Leandro, M. Principi, F. Giorgio, L. Montenegro, C. Sorrentino, E. Ierardi, A. Di Leo

Research output: Contribution to journalArticle

Abstract

Background Sequential therapy is a first-line regimen obtaining satisfactory Helicobacter pylori eradication. Triple therapy prolongation improves the success rate even if a recent meta-analysis showed satisfying results only for the 14-day regimen. Studies from Africa and North America were unavailable in previous meta-analyses. Aim To perform a meta-analysis comparing sequential vs. prolonged 14-day triple therapy with regard to 'geographic weighting' by considering subgroups analysis according to metronidazole/clarithromycin low and high resistance areas. Methods Based on PRISMA recommendations, we considered all first-line clinical studies from 2003 to November 2014. Randomised clinical trials (RCTs) were included by a search on PubMed, MEDLINE, Science Direct, EMBASE. Data on eradication rates were expressed as ITT. Risk ratio (RR), pooled RR and 95% confidence intervals were calculated by the Mantel-Haenszel method. Data were entered into RevMan 5.2 software (Nordic Cochrane Centre) using a random-effects model. Results Databases identified 194 studies; seven met the inclusion criteria. Overall results showed a similar effectiveness of the two regimens considered (RR = 0.99; 95% CI = 0.94-1.05; p = 0.75). In areas with high resistance to clarithromycin, sequential was superior to 14-day triple therapy (RR = 0.95; 95% CI = 0.90-1.00; p = 0.03). In areas with high metronidazole resistance, sequential and 14-day triple therapy were equivalent (RR = 0.99; 95% CI = 0.91-1.08; p = 0.82). Conclusions 'Geographic weighting' could be the main factor affecting the lack of differences between sequential and 14-day triple therapy outcomes.

Original languageEnglish
Pages (from-to)1112-1120
Number of pages9
JournalInternational Journal of Clinical Practice
Volume69
Issue number10
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Helicobacter pylori
Meta-Analysis
Odds Ratio
Clarithromycin
Metronidazole
Therapeutics
North America
PubMed
MEDLINE
Software
Randomized Controlled Trials
Databases
Confidence Intervals

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication : The meta-analysis may be influenced by 'geographical weighting'. / Losurdo, G.; Leandro, G.; Principi, M.; Giorgio, F.; Montenegro, L.; Sorrentino, C.; Ierardi, E.; Di Leo, A.

In: International Journal of Clinical Practice, Vol. 69, No. 10, 01.10.2015, p. 1112-1120.

Research output: Contribution to journalArticle

Losurdo, G. ; Leandro, G. ; Principi, M. ; Giorgio, F. ; Montenegro, L. ; Sorrentino, C. ; Ierardi, E. ; Di Leo, A. / Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication : The meta-analysis may be influenced by 'geographical weighting'. In: International Journal of Clinical Practice. 2015 ; Vol. 69, No. 10. pp. 1112-1120.
@article{f52f415a5a9e40f6b88484c2b69d80b9,
title = "Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: The meta-analysis may be influenced by 'geographical weighting'",
abstract = "Background Sequential therapy is a first-line regimen obtaining satisfactory Helicobacter pylori eradication. Triple therapy prolongation improves the success rate even if a recent meta-analysis showed satisfying results only for the 14-day regimen. Studies from Africa and North America were unavailable in previous meta-analyses. Aim To perform a meta-analysis comparing sequential vs. prolonged 14-day triple therapy with regard to 'geographic weighting' by considering subgroups analysis according to metronidazole/clarithromycin low and high resistance areas. Methods Based on PRISMA recommendations, we considered all first-line clinical studies from 2003 to November 2014. Randomised clinical trials (RCTs) were included by a search on PubMed, MEDLINE, Science Direct, EMBASE. Data on eradication rates were expressed as ITT. Risk ratio (RR), pooled RR and 95{\%} confidence intervals were calculated by the Mantel-Haenszel method. Data were entered into RevMan 5.2 software (Nordic Cochrane Centre) using a random-effects model. Results Databases identified 194 studies; seven met the inclusion criteria. Overall results showed a similar effectiveness of the two regimens considered (RR = 0.99; 95{\%} CI = 0.94-1.05; p = 0.75). In areas with high resistance to clarithromycin, sequential was superior to 14-day triple therapy (RR = 0.95; 95{\%} CI = 0.90-1.00; p = 0.03). In areas with high metronidazole resistance, sequential and 14-day triple therapy were equivalent (RR = 0.99; 95{\%} CI = 0.91-1.08; p = 0.82). Conclusions 'Geographic weighting' could be the main factor affecting the lack of differences between sequential and 14-day triple therapy outcomes.",
author = "G. Losurdo and G. Leandro and M. Principi and F. Giorgio and L. Montenegro and C. Sorrentino and E. Ierardi and {Di Leo}, A.",
year = "2015",
month = "10",
day = "1",
doi = "10.1111/ijcp.12687",
language = "English",
volume = "69",
pages = "1112--1120",
journal = "International Journal of Clinical Practice",
issn = "1368-5031",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication

T2 - The meta-analysis may be influenced by 'geographical weighting'

AU - Losurdo, G.

AU - Leandro, G.

AU - Principi, M.

AU - Giorgio, F.

AU - Montenegro, L.

AU - Sorrentino, C.

AU - Ierardi, E.

AU - Di Leo, A.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background Sequential therapy is a first-line regimen obtaining satisfactory Helicobacter pylori eradication. Triple therapy prolongation improves the success rate even if a recent meta-analysis showed satisfying results only for the 14-day regimen. Studies from Africa and North America were unavailable in previous meta-analyses. Aim To perform a meta-analysis comparing sequential vs. prolonged 14-day triple therapy with regard to 'geographic weighting' by considering subgroups analysis according to metronidazole/clarithromycin low and high resistance areas. Methods Based on PRISMA recommendations, we considered all first-line clinical studies from 2003 to November 2014. Randomised clinical trials (RCTs) were included by a search on PubMed, MEDLINE, Science Direct, EMBASE. Data on eradication rates were expressed as ITT. Risk ratio (RR), pooled RR and 95% confidence intervals were calculated by the Mantel-Haenszel method. Data were entered into RevMan 5.2 software (Nordic Cochrane Centre) using a random-effects model. Results Databases identified 194 studies; seven met the inclusion criteria. Overall results showed a similar effectiveness of the two regimens considered (RR = 0.99; 95% CI = 0.94-1.05; p = 0.75). In areas with high resistance to clarithromycin, sequential was superior to 14-day triple therapy (RR = 0.95; 95% CI = 0.90-1.00; p = 0.03). In areas with high metronidazole resistance, sequential and 14-day triple therapy were equivalent (RR = 0.99; 95% CI = 0.91-1.08; p = 0.82). Conclusions 'Geographic weighting' could be the main factor affecting the lack of differences between sequential and 14-day triple therapy outcomes.

AB - Background Sequential therapy is a first-line regimen obtaining satisfactory Helicobacter pylori eradication. Triple therapy prolongation improves the success rate even if a recent meta-analysis showed satisfying results only for the 14-day regimen. Studies from Africa and North America were unavailable in previous meta-analyses. Aim To perform a meta-analysis comparing sequential vs. prolonged 14-day triple therapy with regard to 'geographic weighting' by considering subgroups analysis according to metronidazole/clarithromycin low and high resistance areas. Methods Based on PRISMA recommendations, we considered all first-line clinical studies from 2003 to November 2014. Randomised clinical trials (RCTs) were included by a search on PubMed, MEDLINE, Science Direct, EMBASE. Data on eradication rates were expressed as ITT. Risk ratio (RR), pooled RR and 95% confidence intervals were calculated by the Mantel-Haenszel method. Data were entered into RevMan 5.2 software (Nordic Cochrane Centre) using a random-effects model. Results Databases identified 194 studies; seven met the inclusion criteria. Overall results showed a similar effectiveness of the two regimens considered (RR = 0.99; 95% CI = 0.94-1.05; p = 0.75). In areas with high resistance to clarithromycin, sequential was superior to 14-day triple therapy (RR = 0.95; 95% CI = 0.90-1.00; p = 0.03). In areas with high metronidazole resistance, sequential and 14-day triple therapy were equivalent (RR = 0.99; 95% CI = 0.91-1.08; p = 0.82). Conclusions 'Geographic weighting' could be the main factor affecting the lack of differences between sequential and 14-day triple therapy outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84942821849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942821849&partnerID=8YFLogxK

U2 - 10.1111/ijcp.12687

DO - 10.1111/ijcp.12687

M3 - Article

AN - SCOPUS:84942821849

VL - 69

SP - 1112

EP - 1120

JO - International Journal of Clinical Practice

JF - International Journal of Clinical Practice

SN - 1368-5031

IS - 10

ER -